271 related articles for article (PubMed ID: 36187880)
1. Growing challenge of post-liver transplantation non-alcoholic fatty liver disease.
Kalogirou MS; Giouleme O
World J Transplant; 2022 Sep; 12(9):281-287. PubMed ID: 36187880
[TBL] [Abstract][Full Text] [Related]
2. Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis.
Villeret F; Dharancy S; Erard D; Abergel A; Barbier L; Besch C; Boillot O; Boudjema K; Coilly A; Conti F; Corpechot C; Duvoux C; Faitot F; Faure S; Francoz C; Giostra E; Gugenheim J; Hardwigsen J; Hilleret MN; Hiriart JB; Houssel-Debry P; Kamar N; Lassailly G; Latournerie M; Pageaux GP; Samuel D; Vanlemmens C; Saliba F; Dumortier J
JHEP Rep; 2023 Mar; 5(3):100668. PubMed ID: 36852108
[TBL] [Abstract][Full Text] [Related]
3. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.
Said A
World J Gastroenterol; 2013 Dec; 19(48):9146-55. PubMed ID: 24409043
[TBL] [Abstract][Full Text] [Related]
5. NAFLD and liver transplantation: Disease burden, current management and future challenges.
Burra P; Becchetti C; Germani G
JHEP Rep; 2020 Dec; 2(6):100192. PubMed ID: 33163950
[TBL] [Abstract][Full Text] [Related]
6. NASH After Liver Transplantation: Impact of Immunosuppression.
Taneja S; Roy A; Duseja A
J Clin Exp Hepatol; 2023; 13(5):835-840. PubMed ID: 37693259
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges.
Dooghaie Moghadam A; Eslami P; Razavi-Khorasani N; Moazzami B; Zahedi-Tajrishi F; Farokhi E; Makhdoomi Sharabiani K; Mansour-Ghanaei A; Mehrvar A; Aghajanpoor Pasha M; Saeedi S; Iravani S
Caspian J Intern Med; 2020; 11(4):346-354. PubMed ID: 33680375
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant Non-alcoholic Fatty Liver Disease and Metabolic Syndrome After Living Donor Liver Transplantation in Indians.
Choudhary NS; Dhampalwar S; Saraf N; Rastogi A; Bhangui P; Soin AS
J Clin Exp Hepatol; 2024; 14(2):101281. PubMed ID: 38076440
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management.
Battistella S; D'Arcangelo F; Grasso M; Zanetto A; Gambato M; Germani G; Senzolo M; Russo FP; Burra P
Clin Mol Hepatol; 2023 Feb; 29(Suppl):S286-S301. PubMed ID: 36577425
[TBL] [Abstract][Full Text] [Related]
10. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
Pallayova M; Taheri S
Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
[TBL] [Abstract][Full Text] [Related]
11. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.
Khullar V; Dolganiuc A; Firpi RJ
World J Transplant; 2014 Jun; 4(2):81-92. PubMed ID: 25032097
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis after liver transplantation: a systematic review and meta-analysis.
Silva AC; Nogueira P; Machado MV
Liver Transpl; 2023 Apr; 29(4):431-448. PubMed ID: 36735478
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic steatohepatitis recurrence after liver transplant.
Taneja S; Roy A
Transl Gastroenterol Hepatol; 2020; 5():24. PubMed ID: 32258528
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease: An expanded review.
Benedict M; Zhang X
World J Hepatol; 2017 Jun; 9(16):715-732. PubMed ID: 28652891
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
16. New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation.
Andrade AR; Bittencourt PL; Codes L; Evangelista MA; Castro AO; Sorte NB; Almeida CG; Bastos JA; Cotrim HP
Ann Hepatol; 2017 November-December,; 16(6):932-940. PubMed ID: 29055928
[TBL] [Abstract][Full Text] [Related]
17. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.
Ong J; Younossi ZM
Am J Gastroenterol; 2010 Mar; 105(3):621-3. PubMed ID: 20203643
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Liver Disease--The Clinician's Perspective.
Agrawal S; Duseja A
Trop Gastroenterol; 2014; 35(4):212-21. PubMed ID: 26349165
[TBL] [Abstract][Full Text] [Related]
20. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
